Chengdu Easton Biopharmaceuticals Co Ltd Financial Flexibility Index
Chengdu Easton Biopharmaceuticals Co Ltd financial flexibility index. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥85.65 Million (operating CF CN¥61.35 Million minus capex CN¥24.30 Million) represents 0% of total liabilities (CN¥692.94 Million). Explore capital reinvestment ratio of Chengdu Easton Biopharmaceuticals Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2024)
Financial flexibility index of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2024. Historical Financial Flexibility Index trend for Chengdu Easton Biopharmaceuticals Co Ltd across 12 annual periods. Check cash flow reinvestment rate of Chengdu Easton Biopharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Chengdu Easton Biopharmaceuticals Co Ltd Financial Flexibility Index by Year (2013–2024)
Chengdu Easton Biopharmaceuticals Co Ltd financial flexibility index by year from 2013 to 2024. Year-by-year free cash flow to debt coverage for Chengdu Easton Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Chengdu Easton Biopharmaceuticals Co Ltd (688513) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | CN¥380.66 Million | CN¥263.24 Million | CN¥702.21 Million | ▼ -10.6% |
| 2023 | 0.61x | CN¥450.51 Million | CN¥275.25 Million | CN¥743.33 Million | ▼ -29.3% |
| 2022 | 0.86x | CN¥491.27 Million | CN¥151.94 Million | CN¥573.08 Million | ▲ +2.6% |
| 2021 | 0.84x | CN¥403.89 Million | CN¥147.60 Million | CN¥483.60 Million | ▲ +2.4% |
| 2020 | 0.82x | CN¥355.33 Million | CN¥156.52 Million | CN¥435.61 Million | ▼ -0.4% |
| 2019 | 0.82x | CN¥237.24 Million | CN¥141.83 Million | CN¥289.64 Million | ▼ -30.2% |
| 2018 | 1.17x | CN¥243.42 Million | CN¥166.79 Million | CN¥207.50 Million | ▲ +58.3% |
| 2017 | 0.74x | CN¥108.72 Million | CN¥85.70 Million | CN¥146.70 Million | ▼ -22.0% |
| 2016 | 0.95x | CN¥123.88 Million | CN¥106.06 Million | CN¥130.43 Million | ▼ -52.0% |
| 2015 | 1.98x | CN¥86.00 Million | CN¥50.57 Million | CN¥43.42 Million | ▲ +130.1% |
| 2014 | 0.86x | CN¥68.75 Million | CN¥46.71 Million | CN¥79.85 Million | ▼ -28.8% |
| 2013 | 1.21x | CN¥104.23 Million | CN¥28.12 Million | CN¥86.24 Million | — |